Syntaxin-1B (STX1B)

Syntaxin-1B (STX1B)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Syntaxin-1B (STX1B)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Syntaxin-1B</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>[STX1B](/proteins/stx1b-protein)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P61264](https://www.uniprot.org/uniprot/P61264)</td>
</tr>
<tr>
<td class="label">PDB Structure ID</td>
<td>[1BR0](https://www.rcsb.org/structure/1BR0), [3C98](https://www.rcsb.org/structure/3C98)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>35.6 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>288</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Presynaptic plasma membrane, Synaptic vesicles</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Syntaxin family, SNARE proteins</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Cerebellum, Basal ganglia</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Epilepsy</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus (CA1, CA3)</td>
<td>High</td>
</tr>
<tr>
<td cla

Syntaxin-1B (STX1B)

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Syntaxin-1B (STX1B)</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Syntaxin-1B</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>[STX1B](/proteins/stx1b-protein)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[P61264](https://www.uniprot.org/uniprot/P61264)</td>
</tr>
<tr>
<td class="label">PDB Structure ID</td>
<td>[1BR0](https://www.rcsb.org/structure/1BR0), [3C98](https://www.rcsb.org/structure/3C98)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>35.6 kDa</td>
</tr>
<tr>
<td class="label">Amino Acids</td>
<td>288</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Presynaptic plasma membrane, Synaptic vesicles</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Syntaxin family, SNARE proteins</td>
</tr>
<tr>
<td class="label">Brain Expression</td>
<td>[Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Cerebellum, Basal ganglia</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, ALS, Epilepsy</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus (CA1, CA3)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum (Purkinje cells)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Basal Ganglia</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>Moderate</td>
</tr>
</table>

Syntaxin-1B (STX1B) is a critical SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) protein essential for synaptic vesicle fusion and neurotransmitter release. As a member of the syntaxin family, STX1B plays a fundamental role in presynaptic terminal function and is implicated in various neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). This page provides comprehensive coverage of STX1B structure, function, mechanisms, and therapeutic relevance.
title: Syntaxin-1B (STX1B)
.infobox.infobox-protein

Overview

Syntaxin-1B is a presynaptic membrane protein that mediates synaptic vesicle fusion through formation of the SNARE complex. STX1B is widely expressed throughout the central nervous system, with particularly high expression in the cerebral cortex, hippocampus, cerebellum, and basal ganglia [@binz1993]. The protein is localized to the presynaptic plasma membrane where it interacts with SNAP-25 and VAMP2 to form the core SNARE complex responsible for Ca²⁺-triggered neurotransmitter release.

STX1B exists in two major isoforms (STX1B-1 and STX1B-2) generated by alternative splicing, which exhibit slightly different expression patterns and functional properties [@greaves2012]. The protein is essential for normal synaptic transmission, and dysregulation of STX1B function has been implicated in multiple neurodegenerative diseases.

Structure

Domain Architecture

The STX1B protein contains several distinct structural domains:

Structural Conformations

STX1B adopts two primary conformational states:

• Closed conformation: The Habc domain folds back to interact with the SNARE motif, preventing SNARE complex assembly
• Open conformation: The Habc domain disengages, allowing SNARE motif to participate in complex formation

Normal Function

Synaptic Vesicle Fusion

STX1B is a central component of the neurotransmitter release machinery:

Regulation of Release

STX1B function is tightly regulated by multiple mechanisms:

• Munc18-1 binding: STX1B interacts with Munc18-1, which is essential for SNARE complex assembly and synaptic vesicle priming [@shen2007]
• Complexin binding: Complexin stabilizes the SNARE complex in a fusion-competent state
• Phosphorylation: STX1B phosphorylation by casein kinases modulates release probability

Additional Functions

Beyond synaptic transmission, STX1B participates in:

• Axonal transport: KIF2A motor domain interactions mediate microtubule-based transport
• [Autophagy](/entities/autophagy): STX17 (related syntaxin) mediates autophagosome-lysosome fusion
• Lysosomal trafficking: Syntaxin proteins regulate endosomal and lysosomal fusion events

Role in Disease

Alzheimer's Disease

STX1B dysfunction contributes to multiple aspects of AD pathogenesis:

Synaptic Failure: Early synaptic dysfunction in AD involves impaired SNARE complex formation. [Aβ](/proteins/amyloid-beta) oligomers directly interact with STX1B and SNAP-25, disrupting the pre-synaptic release machinery [@parodi2010]. Studies show reduced STX1B levels in AD temporal cortex, correlating with cognitive decline.

Axonal Transport Defects: [Tau](/proteins/tau) pathology disrupts STX1B transport in axons. Hyperphosphorylated [tau](/proteins/tau) impairs kinesin-based transport of STX1B-containing vesicles, contributing to presynaptic dysfunction.

Therapeutic Implications: Enhancing SNARE complex formation represents a potential therapeutic strategy. Small molecules that stabilize STX1B-SNAP-25 interactions are under investigation.

Parkinson's Disease

In PD, STX1B dysfunction relates to:

Synaptic Vesicle Recycling: STX1B is essential for normal synaptic vesicle endocytosis and recycling. PD-linked mutations in genes like LRRK2 affect synaptic vesicle dynamics involving STX1B.

Dysautonomia: STX1B is expressed in autonomic [neurons](/entities/neurons), and its dysfunction may contribute to gastrointestinal symptoms in PD.

Amyotrophic Lateral Sclerosis (ALS)

STX1B alterations in ALS include:

Impaired Transport: Mutations in dynein/dynactin disrupt STX1B axonal transport, leading to presynaptic deficits.

Synaptic Hyperexcitability: Altered STX1B and SNARE complex stoichiometry may contribute to hyperexcitability observed in ALS motor neurons.

Epilepsy

STX1B mutations cause familial epilepsy [@schubert2016]. Loss-of-function variants disrupt synaptic inhibition and excitation balance, lowering seizure threshold.

Interaction Network

Core SNARE Partners

• VAMP2 (Synaptobrevin-2): R-SNARE partner in the core complex
• SNAP-25: Q-SNARE partner providing two coiled-coil domains
• SNAP-23: Alternative Q-SNARE in non-neuronal cells

Regulatory Proteins

• Munc18-1 (STXBP1): Essential scaffolding protein
• Munc13-1: Priming factor that opens STX1B
• Complexin-1/2: Clamp that stabilizes SNARE complexes
• Synaptotagmin-1: Ca²⁺ sensor for triggered release

Motor Proteins

• KIF2A: Kinesin that transports STX1B-containing vesicles
• Dynein: Retrograde transport motor

Disease-Associated Interactions

• [APP](/entities/app-protein): Amyloid precursor protein interactions
• [Tau](/proteins/tau) (MAPT): Pathological interactions affecting transport
• [α-Synuclein](/proteins/alpha-synuclein) (SNCA): Synucleinopathies affect SNARE function

Brain Region Distribution

STX1B expression varies across brain regions:

Therapeutic Targeting

Current Approaches

No FDA-approved drugs directly target STX1B, but several strategies are in development:

Challenges

• [Blood-brain barrier](/entities/blood-brain-barrier) penetration
• Specificity for STX1B over other syntaxins
• Maintaining physiological regulation of release

Research Directions

Current research focuses on:

• Cryo-EM structure of native SNARE complexes
• Single-molecule studies of fusion dynamics
• Patient-derived neurons modeling STX1B dysfunction
• High-throughput screening for SNARE modulators

Background

The study of Syntaxin 1B (Stx1B) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [STX1B Gene](/mechanisms/dopaminergic-neuron-vulnerability)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Axonal Transport Pathway](/mechanisms/dopaminergic-neuron-vulnerability)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [SNARE Complex](/proteins/snare-complex)
• [VAMP2 Protein](/proteins/vamp2-protein)
• [SNAP](/proteins/snap25-protein)

External Links

• [UniProt: P61264](https://www.uniprot.org/uniprot/P61264)
• [PDB: 1BR0](https://www.rcsb.org/structure/1BR0)
• [PDB: 3C98](https://www.rcsb.org/structure/3C98)
• [NCBI Gene: STX1B](https://www.ncbi.nlm.nih.gov/gene/?term=STX1B)
• [HGNC: STX1B](https://www.genenames.org/data/hgnc_data.php/hgnc_id:11411)

References